|
Constipation: A Significant Clinical Problem Affecting Quality of Life
Jointly presented by The Johns Hopkins University School of Medicine and the American Academy of Nurse Practitioners.
Supported by an educational grant from Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals North America, Inc.
Release Date: June 1, 2009 Expiration Date: June 1, 2010
ESTIMATED TIME TO COMPLETE THIS EDUCATIONAL ACTIVITY
This activity should take approximately 1 hour to complete.
NEEDS STATEMENT
Significant challenges associated with developing objective clinical measures for the diagnosis of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC) contribute considerably to the misdiagnosis and underdiagnosis of these conditions. This article is part of the Educational Initiative on Constipation (EIC), which addresses knowledge gaps related to the identification, pathophysiology, diagnosis, and therapeutic management of IBS-C and CC. The EIC will cover 4 main areas in which participants' educational needs have been identified:
- Current approaches to the treatment of CC
- Pathophysiology, diagnosis, and management of patients with CC (including quality-of-life issues)
- Maximizing therapeutic strategies in patients with CC
- Role of multidisciplinary care in the treatment of patients with CC
TARGET AUDIENCE
This activity was developed for gastroenterologists, primary care physicians, nurse practitioners, and physician assistants. There are no prerequisites.
LEARNING OBJECTIVES
At the conclusion of this activity, participants should be better prepared to:
- Increase their knowledge of the key mechanisms underlying IBS-C and CC.
- Review clinical data related to current and emerging therapies for IBS-C and CC.
- Implement diagnostic and management strategies for IBS-C and CC, with appropriate use of diagnostic criteria and measures.
- Consider the need for a multidisciplinary approach to the management of patients with IBS-C and CC.
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The Johns Hopkins University School of Medicine and the American Academy of Nurse Practitioners (AANP). The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
This activity was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standard.
CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
This activity has been approved for 1.0 contact hour of continuing education by the AANP. Activity ID 0812592.
METHOD OF PARTICIPATION
There are no fees for participating in and receiving credit for this activity. The participant should, in order, read the objectives and monograph, answer the multiple-choice online post-test and complete the evaluation form. The evaluation form provides each participant with the opportunity to comment on the quality of the instructional process, the perception of enhanced professional effectiveness, the perception of commercial bias, and his/her views on future educational needs. A score of at least 70% is required to successfully complete this activity. After the activity has been passed, a certificate will be displayed on screen that participants can print and keep for their records. If the post-test is failed, a screen will appear alerting participants of their current score and displaying the questions that have been answered incorrectly. One retake is allowed. Credit is available through June 1, 2010.
FACULTY
Mark Donowitz, MD (Co-Chair)
Director, The Hopkins Center for Epithelial Disorders
LeBoff Professor for Research in Digestive Diseases
Professor of Medicine and Physiology
The Johns Hopkins University School of Medicine
Baltimore, Maryland
Henry P. Parkman, MD (Co-Chair)
Director, Gastrointestinal Motility Laboratory
Director, Temple Clinical Research Unit
Chair, Research Committee, Department of Medicine
Professor of Medicine
Temple University School of Medicine
Philadelphia, Pennsylvania
Julia Pallentino, MSN, JD, ARNP-BC, FNP
Clinical Practice in Gastroenterology
GI Associates of Tallahassee
Adjunct Professor
Florida State University College of Nursing
Tallahassee, Florida
FACULTY DISCLOSURE
As a provider accredited by the ACCME, it is the policy of The Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a provider has with the manufacturers of any commercial products discussed in an educational presentation. The presenting faculty or authors reported the following:
Mark Donowitz, MD, has received honoraria from Sucampo Pharmaceuticals, Inc.; held stock in Tranzmembrane, Inc. (holder of NHE3 patent); and served on the scientific advisory board for the Institute for One World Health.
Henry P. Parkman, MD, has received grants/research support from Medtronic, Inc., SmartPill Corporation, and Tranzyme Pharma, Inc.; served as a consultant for SmartPill Corporation and Tranzyme Pharma, Inc.; and served on the speakers' bureau for SmartPill Corporation.
Julia Pallentino, MSN, JD, ARNP-BC, FNP, has served on speakers' bureaus for AstraZeneca, Proctor & Gamble, Roche, Takeda Pharmaceuticals North America, Inc., and UCB Pharma.
OFF-LABEL PRODUCT DISCUSSION
No faculty members or authors have indicated that their presentation will include off-label information.
DISCLAIMER
The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This enduring material is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine name or the Applied Clinical Education name, implies review of educational format design and approach. Please review the complete prescribing information for specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.
SOFTWARE REQUIREMENTS
PC
Microsoft Windows 2000 SE or above.
Internet Explorer (v5.5 or greater), or Firefox
Adobe Acrobat Reader*
MAC
MAC OS 10.2.8
Safari
Adobe Acrobat Reader*
Internet Explorer is not supported on the Macintosh.
* Required to view printable (PDF) version of the lesson.
Copyright © 2009 The Johns Hopkins University School of Medicine. All rights reserved. No part of this syllabus may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations included in articles or reviews.
|